Interaction between prostacyclin and nitric oxide in the reflex control of the coronary circulation in conscious dogs

Cardiovascular Research

Volumn 32, Issue 5, 1996, Pages 940-948

  Zhao, Gong ^a   Xu, Xiaobin ^a   Ochoa, Manuel ^a   Shen, Weiqun ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

coronary blood flow; dog, conscious; indomethacin; L nitro arginine; nitric oxide; prostacyclin; vasodilation

Indexed keywords

ACETYLCHOLINE; ARGININE; ATROPINE; GLYCERYL TRINITRATE; INDOMETACIN; N(G) NITROARGININE; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ATROPINE; CORONARY CIRCULATION; DOGS; EPOPROSTENOL; INDOMETHACIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; NITROGLYCERIN; PARASYMPATHOLYTICS; PROPRANOLOL; PROSTAGLANDIN ANTAGONISTS; REFLEX; SYMPATHOLYTICS; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 0030296401     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00143-5     Document Type: Article

References (36)

1. [1] Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-2018.
2. [2] Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, pharmacology. Pharmacol Rev 1991;43:109-142.
3. [3] Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
4. [4] Burnstock G. Integration of factors controlling vascular tone. Anesthesiology 1993;79:1368-1380.
5. [5] Davies MG, Hagen PO. The vascular endothelium. Ann Surg 1993;218:593-609.
6. [6] Chan PS, Cervoni P. Prostaglandins, prostacyclin, and thromboxane in cardiovascular diseases. Drug Dev Res 1986;7:341-359.
7. [7] Frolich JC. Prostacyclin in hypertension. J Hypertension 1990;8(Suppl. 4):573-578.
8. [8] Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides: a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976;12:897-913.
9. [9] Dusting GJ, Moncada S, Vane JR. Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins 1977;13:3-15.
10. 2) on tissues which detect prostaglandins (PG's). Prostaglandins 1977;14:625-632.
11. [11] Smirnov IE, Mentz PR, Markov ChM. Effect of Prostacyclin on coronary blood flow and cardiac activity in normotensive and spontaneously hypertensive rats. Adv Prost Thromb Res 1980;7:631-633.
12. 2) induces coronary vasodilation in anesthetized dogs. Cardiovasc Res 1978;12:720-730.
13. [13] Capurro NL, Lipson LC, Bonow RO, Goldstein RE, Shulman NR, Epstein SE. Relative effects of aspirin on platelet aggregation and prostaglandin-mediated coronary vasodilation in the dog. Circulation 1980;62:1221-1227.
14. 2 in anesthetized dogs. Br J Pharmacol 1980;68:437-447.
15. [15] Coker SJ, Parratt JR. Prostaglandin-induced changes in coronary blood flow and oxygen handling in the normal and acutely ischemic canine myocardium. Basic Res Cardiol 1981;76:457-462.
16. [16] Hintze TH, Kaley G. Ventricular receptors activated following myocardial prostaglandin synthesis initiate reflex hypotension, reduction in heart rate, and redistribution of cardiac output in the dog. Circ Res 1984;54:239-247.
17. 2) elicits reflex bradycardia in dogs: evidence for vagal mediation. Proc Soc Exp Biol Med 1979;162:96-100.
18. [18] Shen WQ, Ochoa M, Xu XB, Wang J, Hintze TH. Role of endothelium-derived relaxing factor in parasympathetic coronary vasodilation following carotid chemoreflex activation in conscious dogs. Am J Physiol 1994;267:H605-H613.
19. [19] Zhao G, Shen WQ, Xu XB, Ochoa M, Bernstein R, Hintze TH. Selective impairment of vagalty mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure. Circulation 1995;91:2655-2663.
20. [20] Hintze TH, Vatner SF. Reactive dilation of large coronary arteries in conscious dogs. Circ Res 1984;54:50-57,
21. [21] Hintze TH, Stem H, Kaley G. Effect of leukotriene D4 on large and small coronary arteries in the conscious dogs. Adv Prost Thromb LeukRes 1986;16:287-298.
22. [22] Baumann JE, Persson PB, Ehmke H, Nafz B, Kirchheim HR. Role of endothelium-derived relaxaing factor in renal autoregulation in conscious dogs. Am J Physiol 1992;263:F208-F213.
23. [23] Mehta J, Nichols WW, Mehta P, Pepine C, Conti CR. Effects of prostacyclin on systemic and coronary hemodynamics in the dog. Am Heart J 1981;102:835-840.
24. 2) in hypertensive rats. Clin Sci 1981;61:315s-318s.
25. [25] Ganz P, Gaspar J, Colucci WS, Barry WH, Mudge GH, Alexander RW. Effects of prostacyclin on coronary hemodynamics at rest and in response to cold pressor testing in patients with angina pectoris. Am J Cardiol 1984;53:1500-1504.
26. [26] Theroux P, Latour JG, Diodati J, Leger-Gauthier C, Morissette D, Bosch X, de Lara J, Waters D. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris. Am J Cardiol 1990;65:1084-1089.
27. [27] Koller A, Sun D, Messina EJ, Kaley G. L-Arginine analogues blunt prostaglandin-related dilation of arterioles. Am J Physiol 1993;264:H1194-H1199.
28. [28] Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-7244.
29. 2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. Circ Res 1992;71:1305-1313.
30. [30] Ito BR, Feigl EO. Carotid chemoreceptor reflex parasympathetic coronary vasodilation in the dog. Am J Physiol 1985;249:H1167-H1175.
31. [31] Feigl EO. Reflex parasympathetic coronary vasodilation elicited from cardiac receptors in the dog, Circ Res 1975;37:175-182.
32. [32] Furchgott RF, Zawadzki V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
33. [33] Ignarro LJ. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension 1990;16:477-483.
34. [34] Chu A, Chambers DE, Lui CC, Kuehl WD, Cobb FR. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. AmJPhysiol 1990;258:H1250-H1254.
35. [35] Komara T, Lamping KG, Eastham CL, Harrison DG Marcus, ML, Dellsperger KC. Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilatation in dogs. Am J Physiol 1991;261:H2001-H2007.
36. [36] Parent R, Pare R, Lavallee M. Contribution of nitric oxide to dilation of resistance coronary vessel in conscious dogs. Am J Physiol 1992;262:H10-H16.